DigniCap was the first scalp cooling system to be cleared by the FDA in December of 2015 for the treatment of breast cancer patients in the U.S. In July 2017, DigniCap clinical indications were expanded to include solid tumor cancers in men and women.
DigniCap incorporates a number of patented features and technological advances that combine to improve the patient experience. The cooling cap has two dedicated temperature regulation sensors in each cap that monitors scalp temperature and a third safety sensor to ensure that the scalp temperature never falls below freezing point. Also, the cooling cap is fitted once at the start of treatment and remains on until completion. For a detailed comparison of DigniCap and manual scalp cooling approaches click here